Literature DB >> 1654360

Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction.

R W Cone1, A C Hobson, J Palmer, M Remington, L Corey.   

Abstract

To evaluate the utility of the polymerase chain reaction (PCR) for documenting herpes simplex virus (HSV) in persons with reactivated genital lesions viral isolation was compared with a recently developed PCR method. Three women experiencing four episodes of recurrent genital herpes were followed for 10 days per episode with daily examination and duplicate swabs of the lesions, one for HSV culture and one for PCR. HSV type 2 was cultured from three of four episodes and the mean duration of viral isolation from recurrent genital lesions was 2.6 days. PCR detected HSV DNA from lesion swabs during all four episodes, and HSV DNA was positive for an average of 6.8 days. HSV DNA was demonstrated in ulcerative lesions on 15 of 17 days versus 3 of 17 days by viral isolation (P less than .01). HSV PCR became negative when the lesions reepithelialized. These data suggest that PCR is a more sensitive measure of HSV infection than routine viral culture and that PCR detects the presence of HSV at times when culture is negative.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654360     DOI: 10.1093/infdis/164.4.757

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Coamplified positive control detects inhibition of polymerase chain reactions.

Authors:  R W Cone; A C Hobson; M L Huang
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

3.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

4.  The laboratory diagnosis of herpes simplex virus infections.

Authors:  Ameeta Singh; Jutta Preiksaitis; Alex Ferenczy; Barbara Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

5.  Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR.

Authors:  M C do Nascimento; L M Sumita; V A de Souza; C S Pannuti
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 6.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

7.  Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions.

Authors:  A Hobson; A Wald; N Wright; L Corey
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

8.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

9.  Coinfection with human herpesvirus 6 variants A and B in lung tissue.

Authors:  R W Cone; M L Huang; R C Hackman; L Corey
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.